Netherlands· NL-c4169948eaa8

Angusta 25 microgram tabletten

A misoprostol product containing misoprostol, registered in Netherlands by Norgine B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC G02AD06

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about misoprostolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Misoprostol is registered in 11 of 19 countries.

Countries holding a registration under ATC G02AD06 (misoprostol), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search misoprostol products by name

Misoprostol · ATC G02AD06

11 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of misoprostol costs, country by country.

Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Misoprostol · price per daily dose (0.2 mg)

USD · FX 28 Sept 2026

US United States$0.72 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MISOPROSTOL
Manufacturer: Norgine B.V.
Country: Netherlands (NL)
ATC code: G02AD06
ATC class: Misoprostol
Defined daily dose: 0.2 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
126719

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

245 interactions on record for misoprostol.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check misoprostol against other medicines How interaction checks work

Misoprostol · interactions on record

245 records

10 moderate
6 minor
229 info

Most severe, free to view

Magnesium carbonateA02AA01moderate
Magnesium oxideA02AA02moderate
Magnesium hydroxideA02AA04moderate
Kombinationen von AluminiumsalzenA02AB10moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Misoprostol in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All misoprostol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Angusta®, Cyprostol
Belgium · Angusta, Cytotec
Bulgaria · Ангуста, Топогин
Cyprus · Angusta, Misoone
Czechia · Angusta, Mispregnol
Germany · Angusta, Misoone
Denmark · Angusta, Cytotec
Estonia · Angusta, Gyxiny
Spain · Angusta, Cytotec
Finland · Angusta, Cytotec
France · Angusta, Gymiso
United Kingdom (Northern Ireland) · Angusta, Cytotec
Greece · Angusta, Cytotec
Croatia · Angusta, Mispregnol
Hungary · Angusta
Ireland · Angusta, Cytotec
Iceland · Angusta, Cytotec
Italy · Angusta, Cytotec
Lithuania · Gyxiny, Misoone
Luxembourg · Angusta, Cytotec
Latvia · Angusta, Gyxiny
Malta · Angusta
Norway · Angusta, Cytotec
Poland · Angusta, Cytotec
Portugal · Angusta, Cytotec
Romania · Angusta, Topogyne
Sweden · Angusta, Cytotec
Slovenia · Angusta, Topogyne
Slovakia · Angusta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c8b38332-4214-4c94-8651-90e63396d55a
GET /v1/drugs/c8b38332-4214-4c94-8651-90e63396d55a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h126719_smpc.pdf",
  "strength": null,
  "atc_label": "Misoprostol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126719",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MAÏSZETMEEL",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "MISOPROSTOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126719.pdf",
  "authorised_at": "2020/09/17",
  "procedure_number": "DK/H/2584/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "126719",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about misoprostol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console